State bills · Health
What's moving in state legislatures -- introductions, committee action, floor votes and sponsors.
Filter bills
-
SB 934 — Missouri
Modifies provisions relating to amending birth certificates
SB 934 - Under current law, a birth certificate may be amended by court order to reflect a surgical sex change. This act prohibits amending a birth certificate when the sex of an individual has been changed by non-surgical means. Additionally, no birth certificate shall be amended if the sex of the individual was changed for reasons other than a medically-verifiable disorder of sex development or to correct a typographic error. This act is substantially similar to SB 100 (2025) and SB 14 (2023). SARAH HASKINS
-
SB 940 — Missouri
Modifies provisions relating to peer review committees
SB 940 - Under this act, any emergency medical services provider licensed under certain provisions of state law shall be considered a health care professional for purposes of liability and disclosure of materials produced by a peer review committee. Any quality improvement or quality assurance activity required by such licensed individuals shall be considered an activity of a peer review committee. Additionally, this act modifies the definition of a "health care professional" in the context of peer review committees and associated immunities from civil liabilities by adding physician assistants. This act is identical to SB 107 (2025) and SCS/SB 1248 (2024). SARAH HASKINS
-
SB 1014 — Missouri
Modifies the "Jason Flatt/Avery Reine Cantor Act" and repeals and modifies provisions relating to mental health efforts in public schools
SB 1014 - Beginning in the 2027-28 school year and continuing in subsequent school years, this act modifies the "Jason Flatt/Avery Reine Cantor Act" by adding a requirement for school districts to provide at least two hours of suicide prevention training to all licensed educators. For the 2028-29 school year and all subsequent school years, such training shall include risk and protective factors, warning signs, response procedures, and postvention support, as the term "postvention" is defined in the act. The Department of Elementary and Secondary Education (DESE) shall include such information in its guidelines for training or professional development in youth suicide awareness and prevention. The act repeals provisions requiring public schools and charter schools to print certain contact information on identification cards for pupils in grades 7-12. By July 1, 2027, pupil identification cards shall include only the three-digit dialing code for the Suicide and Crisis Lifeline, 988. Any unissued cards that include additional contact information shall continue to be issued until the supply of cards is depleted. For the 2028-29 school year and all subsequent school years, each school district shall update its policy on youth suicide awareness and prevention training for school district employees to include risk and protective factors, warning signs, response procedures, and postvention support. The corresponding model policy currently developed by DESE shall be updated accordingly. Finally, beginning in the 2027-28 school year and in each subsequent school year, the act requires each pupil in a public school to receive mental health awareness training at any time in grades 5-8. Such instruction shall be included in the school district's existing health or physical education curriculum and shall be based on a program established by DESE. This act is similar to SB 695 (2025) and provisions in HB 244 (2025) and HCS/HB 2471 (2024). OLIVIA SHANNON
-
SB 930 — Missouri
Creates provisions relating to anesthesia services
SB 930 - Under this act, no health carrier or health benefit plan shall establish, implement, or enforce any policy that imposes a time limit for the payment of anesthesia services provided during a medical or surgical procedure, as described in the act. This provision is identical to provisions in HCS/SB 94 (2025), HCS/HBs 1126 & 932 (2025), and SCS/HCS/HB 94 (2025), and similar to provisions contained in SCS/SB 841 (2026), HB 2570 (2026), the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026), HCS/HBs 1945 & 2570, and HB 1944 (2026). TAYLOR MIDDLETON
-
SB 846 — Missouri
Enacts provisions relating to insurance coverage of health care services
SB 846 - This act enacts provisions relating to insurance coverage of pharmacy services. CLINICIAN-ADMINISTERED DRUGS (Section 376.411) This act provides that a health carrier or pharmacy benefits manager (PBM) shall not impose any penalty, impediment, differentiation, or limitation on participating providers for providing medically necessary clinician-administered drugs, regardless of whether the participating provider obtains the drugs from an in-network provider, including but not limited to refusing to approve or pay, or reimbursing less than the contracted payment amount. Carriers and PBMs shall not impose any penalty, impediment, differentiation, or limitation on a covered person who is administered medically necessary clinician-administered drugs, regardless of whether the participating provider obtains the drugs from an in-network provider, including but not limited to: limiting coverage or benefits; requiring an additional fee, higher co-payment, or higher coinsurance amount; or interfering with a patient's ability to obtain a clinician-administered drug from the patient's provider or pharmacy of choice by any means, including but not limited to inducing, steering, or offering financial or other incentives. Carriers and PBMs shall not impose any penalty, impediment, differentiation, or limitation on any pharmacy that is dispensing medically necessary clinician-administered drugs, regardless of whether the participating provider obtains the drugs from an in-network provider, including but not limited to requiring a pharmacy to dispense the drugs to a patient with the intention that the patient will transport the medication to a health care provider for administration. These provisions shall not apply if the clinician-administered drug is not otherwise covered by the carrier or PBM. These provisions are identical to provisions in SB 13 (2025), the introduced SB 751 (2024), HCS/HB 2267 (2024), SB 26 (2023), HCS/HB 198 (2023), SB 1129 (2022), and HB 2305 (2022), and similar to provisions in SB 921 (2022), SB 1129 (2022), and HB 2305 (2022). REFERENCE PRODUCTS AND BIOSIMILARS (Section 376.415) A health carrier or PBM providing coverage for a reference product or a biological product that is biosimilar to the reference product shall provide coverage for the reference product and all biological products that have been deemed biosimilar to the reference product. The scope, extent, and amount of the required coverage shall be the same, including but not limited to any payment limitations or cost-sharing obligations. These provisions are identical to provisions in SB 13 (2025), the introduced SB 751 (2024), HCS/HB 2267 (2024), SB 26 (2023), HCS/HB 198 (2023), SB 1129 (2022), and HB 2305 (2022), and similar to provisions in SB 921 (2022), SB 1129 (2022), and HB 2305 (2022). 340B DRUG PRICING PROGRAM (Section 376.416) Under this act, no health carrier or pharmacy benefits manager (PBM) shall discriminate against a covered entity or a pharmacy, as such terms are defined in the act, by: • Reimbursing a covered entity or pharmacy for a quantity of a 340B drug, as defined in the act, in an amount less than the carrier, PBM, or affiliate would pay to any other similarly situated pharmacy for such quantity of the drug on the basis that the entity or pharmacy is a covered entity or a pharmacy, or that the entity or pharmacy dispenses 340B drugs. (Section 376.416.2(1)); • Imposing any terms or conditions on covered entities or pharmacies which differ from the terms or conditions applicable to other similarly situated pharmacies or entities on the basis that the entity or pharmacy is a covered entity or dispenses 340B drugs, including but not limited to certain terms and conditions described in the act. (Section 376.416.2(2)); • Interfering with an individual's choice to receive a 340B drug from a covered entity or pharmacy. (Section 376.416.2(3)); • Discriminating in reimbursement to a covered entity or pharmacy based on the determination or indication a drug is a 340B drug. (Section 376.416.2(4)); • Requiring a covered entity or pharmacy to identify a 340B drug sooner than 45 days after the point of sale of the drug. (Section 376.416.2(5)); • Refusing to contract with a covered entity or pharmacy for reasons other than those that apply equally to entities or pharmacies that are not covered entities or similarly situated pharmacies, or on the basis that the entity or pharmacy is a covered entity as described under federal law, or on the basis that the entity or pharmacy is described as a covered entity under provisions of federal law. (Section 376.416.2(6)); • Denying the covered entity the ability to purchase drugs at 340B program pricing by substituting a rebate discount. (Section 376.416.2(7)); • Refusing to cover drugs purchased under the 340B drug pricing program. (Section 376.416.2(8)); or • Requiring a covered entity or pharmacy to reverse, resubmit, or clarify a 340B-drug pricing claim after the initial adjudication unless these actions are in the normal course of pharmacy business and not related to the 340B drug pricing, except as required by federal law. (Section 376.416.2(9)). The Director of the Department of Commerce and Insurance shall impose a civil penalty on any health carrier or PBM violating certain provisions of the act, not to exceed $5,000 per violation per day. (Section 376.416.3). These provisions are identical to provisions in SB 13 (2025), and similar to provisions in SB 372 (2025), HB 784 (2025), HB 785 (2025), HB 943 (2025), the introduced SB 751 (2024), SCS/SBs 978 & 1035 (2024), SB 1213 (2024), HCS/HB 2267 (2024), HB 1977 (2024), SB 26 (2023), HCS/HB 198 (2023), SB 426 (2023), HB 197 (2023), SB 921 (2022), HCS/HB 1677 (2022), SB 1129 (2022), and HB 2305 (2022). PRIOR AUTHORIZATION OF HEALTH CARE SERVICES (Sections 376.2100, 376.2102, 376.2104, 376.2106, and 376.2108) This act enacts provisions relating to prior authorization of health care services. Beginning January 1, 2027, health care providers shall not be required to obtain prior authorization for a health care service unless the health carrier or utilization review entity determines that in the most recent evaluation period, as defined in the act, less than 90% of the prior authorization requests submitted by that provider for that health care service were approved or would have been approved. Also beginning January 1, 2027, health care providers shall not be required to obtain prior authorization for any health care services unless the health carrier or utilization review entity has approved or would have approved less than 90% of all prior authorization requests submitted by that provider for health care services. Health carriers or utilization review entities may elect to have certain hospitals determine which of certain conditions, laid out in the act, the hospital will comply with in order to obtain a prior authorization exemption under the act. Exemptions from prior authorization under the act shall not apply to: pharmacy services, not to exceed the amount of $100,000; imaging services, not to exceed $100,000; cosmetic procedures that are not medically necessary; or investigative or experimental treatments. Maximum dollar amounts for these exceptions shall be adjusted annually for inflation as described in the act. The act further specifies certain prior authorization requests that shall not be included in making determinations under the act, specifies identification methods for the providers, includes provisions for the auditing and retraction of determinations under the act, allows for health carriers and utilization review entities to require providers to use an online portal to submit prior authorization requests, requires adverse determinations under the act to be reviewed by a clinical peer of the provider, and requires a grace period for patients who have received prior authorization for a 90-day supply of medication. Health carriers and utilization review entities shall notify providers within 25 days after a determination is made under the act, shall include in the notification certain information used in making the determination, shall establish an appeals process for the providers, and shall maintain an online prior authorization portal as described in the act. No health carrier or utilization review entity shall deny or reduce payment to a health care provider for a health care service for which the provider has prior authorization, except as described in the act. These provisions shall not apply to MO HealthNet services not provided through a managed care organization, or to providers who have not participated in a health benefit plan offered by the health carrier for at least one full evaluation period. These provisions are identical to provisions contained in SB 841 (2026), SB 13 (2025), HCS/SS#2/SB 79 (2025), HB 618 (2025), and similar to SB 897 (2026), HCS/HB 3010 (2026), HB 1675 (2026), SB 230 (2025), SB 751 (2024), SB 983 (2024), HB 1976 (2024), HB 2267 (2024), SB 576 (2023), and HB 1045 (2023). TAYLOR MIDDLETON
-
SB 924 — Missouri
Establishes the "Compassionate Assistance for Rape Emergencies (CARE) Act"
SB 924 - This act establishes the "Compassionate Assistance for Rape Emergencies (CARE) Act". Under this act, it shall be the standard of care for any hospital or health care facility that provides emergency care to sexual assault victims to inform each victim of the option to be provided emergency contraception at the hospital or health care facility, provide such emergency contraception to each victim who requests it, and provide sexually transmitted infection screening and treatment to the victim. This act is identical to SB 628 (2025) and substantially similar to HB 2121 (2024). SARAH HASKINS
-
SB 884 — Missouri
Provides that the practice of optometry shall include the use of injectable agents and surgical procedures for certain purposes
SB 884 - Currently, the practice of optometry does not include the provision of surgical procedures, including the use of lasers, and does not include the use of injectable agents. Under this act, the practice of optometry shall include the use of injectable agents for the purpose of treatment of the eye and adnexa and shall include surgical procedures, except as otherwise specified and limited by the Board of Optometry. This act is identical to SB 219 (2025) and HB 929 (2025) and is similar to a provision in HB 2897 (2026), SB 956 (2024), and HB 1963 (2024). KATIE O'BRIEN
-
S 1538 — New York
Relates to optional disability coverage for county probation officers
Provides optional disability coverage for county probation officers.
-
A 2534 — New York
Relates to the definition of practice of pharmacy
Provides for the initiation of treatment for COVID-19, influenza, and pharyngitis resulting from a Group A streptococcal infection by a licensed pharmacist in certain circumstances.
-
A 5601 — New York
Relates to establishing discount programs for low-income senior citizens and individuals with a disability
Relates to establishing discount programs for low-income senior citizens and individuals with a disability; provides that utilities, waterworks corporations, telephone corporations and cable television companies shall create discount programs that provide a 10 percent discount to low-income senior citizens and individuals with a disability; defines terms.
-
A 6648 — New York
Relates to utilization review determinations
Provides that certain utilization review determinations shall be made consistent with medical and scientific evidence; includes services for mental health and substance use disorders as part of emergency services.
-
A 8839 — New York
Prevents discrimination by insurers based on an individual's mental health or substance use disorder
Prevents discrimination by insurers based on an individual's mental health or substance use disorder; incorporates into law federal enforcement rules set forth in the federal mental health parity and addiction equity act of 2008.
-
A 3310 — New York
Establishes under the direction of the state board of pharmacy a drug repository program
Establishes under the direction of the state board of pharmacy a drug repository program to accept and dispense donated prescription drugs; authorizes such board and the commissioner of health to promulgate rules and regulations; makes definitions; exempts such persons or entities who dispense such donated drugs from criminal or tort liability or professional disciplinary action.
-
A 1549 — New York
Relates to enacting Eric's ID Law
Provides for the placement of a discreet nonapparent disability designation on non-driver identification cards, drivers' licenses and learners' permits; makes technical and conforming changes.
-
HB 470 — New Hampshire
relative to the use of general anesthesia, deep sedation, and moderate sedation in dental treatment.
-
HB 725 — New Hampshire
relative to ground ambulance services.
-
HB 233 — New Hampshire
requiring meetings of the New Hampshire vaccine association to be audio and video recorded and published on its website within 48 hours.
-
SB 187 — New Hampshire
adopting the dentist and dental hygienist compact.
-
HB 519 — New Hampshire
making an appropriation to the department of health and human services to fund and support the Waypoint youth and young adult shelter.
-
HB 570 — New Hampshire
repealing the prescription drug affordability board.
-
HB 208 — New Hampshire
relative to certification requirements for school nurses.
-
A 9227 — New York
Relates to certain crimes of interference with health care services or religious worship
Relates to the definition of "reproductive health services" for purposes of the offense of criminal interference with health care services or religious worship in the second degree; defines "legally protected health activity"; increases the penalties for the criminal interference with health care services or religious worship in the first and second degrees, and for aggravated interference with health care services in the second degree.
-
A 7448 — New York
Requires health care providers facilitate a screening for maternal depression within the first six weeks of a person giving birth
Requires maternal health care providers facilitate a screening for maternal depression, unless refused by the birth mother, within the first six weeks of birth and that such screening be covered by insurance.
-
A 8576 — New York
Preserves access to affordable drugs
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.
-
S 6255 — New York
Relates to reimbursement for ambulance services
Relates to reimbursement for ambulance services; requires insurers to submit payments directly to ambulance providers who are in-network or, for out-of-network ambulance providers, requires the issuance of a joint check to the insured specifying both the insured and the ambulance provider as payees.
-
S 357 — New York
Relates to certified registered nurse anesthetists
Defines the practice of certified registered nurse anesthetist; requires collaboration with a licensed physician qualified to determine the need for anesthesia services; requires licensing; defines qualifications.
-
S 7904 — New York
Enacts the "safe haven baby box act"
Enacts the "safe haven baby box act" to provide a defense to endangering the welfare of a child; defines "safe haven baby box" to mean a secure, climate-controlled device installed at a facility staffed twenty-four hours per day, seven days per week, including but not limited to hospitals, police stations, fire stations, and emergency medical service facilities.
-
A 1160 — New York
Relates to making restaurant and bar patios one hundred percent smoke free; repealer
Relates to making restaurant and bar patios one hundred percent smoke free.
-
A 1172 — New York
Authorizes the dispensing of abortion medication
Authorizes the dispensing of abortion medication under certain conditions; requires insurance policies providing coverage for contraception to provide coverage for abortion medication.
-
S 8310 — New York
Enacts the "forensic rehabilitation act"; repealer
Enacts the "forensic rehabilitation act" relating to the custody of individuals following a verdict or plea of not responsible by reason of mental disease or defect.